GB0500604D0 - Novel process - Google Patents

Novel process

Info

Publication number
GB0500604D0
GB0500604D0 GBGB0500604.4A GB0500604A GB0500604D0 GB 0500604 D0 GB0500604 D0 GB 0500604D0 GB 0500604 A GB0500604 A GB 0500604A GB 0500604 D0 GB0500604 D0 GB 0500604D0
Authority
GB
United Kingdom
Prior art keywords
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0500604.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0500604.4A priority Critical patent/GB0500604D0/en
Publication of GB0500604D0 publication Critical patent/GB0500604D0/en
Priority to JP2007550831A priority patent/JP2008526936A/ja
Priority to KR1020077015946A priority patent/KR20070104350A/ko
Priority to NZ556147A priority patent/NZ556147A/en
Priority to BRPI0606639-9A priority patent/BRPI0606639A2/pt
Priority to EP06700281A priority patent/EP1844012A2/en
Priority to AU2006205697A priority patent/AU2006205697B2/en
Priority to PCT/GB2006/000060 priority patent/WO2006075139A2/en
Priority to MX2007008348A priority patent/MX2007008348A/es
Priority to CA002594391A priority patent/CA2594391A1/en
Priority to CN2006800023115A priority patent/CN101102999B/zh
Priority to US11/813,816 priority patent/US7781598B2/en
Priority to IL183965A priority patent/IL183965A0/en
Priority to ZA200705216A priority patent/ZA200705216B/xx
Priority to NO20074047A priority patent/NO20074047L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0500604.4A 2005-01-13 2005-01-13 Novel process Ceased GB0500604D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process
US11/813,816 US7781598B2 (en) 2005-01-13 2006-01-09 Process for the preparation of substituted indoles
AU2006205697A AU2006205697B2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles
MX2007008348A MX2007008348A (es) 2005-01-13 2006-01-09 Procesos nuevos para la preparacion de indoles substituidos.
NZ556147A NZ556147A (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles
BRPI0606639-9A BRPI0606639A2 (pt) 2005-01-13 2006-01-09 novo processo para a preparação de indóis substituìdos
EP06700281A EP1844012A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles
JP2007550831A JP2008526936A (ja) 2005-01-13 2006-01-09 置換インドールの新規製造方法
PCT/GB2006/000060 WO2006075139A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles
KR1020077015946A KR20070104350A (ko) 2005-01-13 2006-01-09 치환된 인돌의 신규 제조 방법
CA002594391A CA2594391A1 (en) 2005-01-13 2006-01-09 Process for the preparation of substituted indoles
CN2006800023115A CN101102999B (zh) 2005-01-13 2006-01-09 制备取代的吲哚的方法
IL183965A IL183965A0 (en) 2005-01-13 2007-06-14 Novel process for the preparation of substituted indoles
ZA200705216A ZA200705216B (en) 2005-01-13 2007-06-29 Novel process for the preparation of substituted indoles
NO20074047A NO20074047L (no) 2005-01-13 2007-08-06 Ny fremgangsmate for fremstilling av substituerte indoler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process

Publications (1)

Publication Number Publication Date
GB0500604D0 true GB0500604D0 (en) 2005-02-16

Family

ID=34203986

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0500604.4A Ceased GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process

Country Status (15)

Country Link
US (1) US7781598B2 (https=)
EP (1) EP1844012A2 (https=)
JP (1) JP2008526936A (https=)
KR (1) KR20070104350A (https=)
CN (1) CN101102999B (https=)
AU (1) AU2006205697B2 (https=)
BR (1) BRPI0606639A2 (https=)
CA (1) CA2594391A1 (https=)
GB (1) GB0500604D0 (https=)
IL (1) IL183965A0 (https=)
MX (1) MX2007008348A (https=)
NO (1) NO20074047L (https=)
NZ (1) NZ556147A (https=)
WO (1) WO2006075139A2 (https=)
ZA (1) ZA200705216B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
CN101454284A (zh) * 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
HUT74614A (en) 1993-02-24 1997-01-28 Merck & Co Inc Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017256A1 (es) 1997-08-21 2001-09-05 American Home Prod Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden
DE69814012T2 (de) 1997-12-19 2004-04-01 Eli Lilly And Co., Indianapolis Hypoglykàmische imidazoline derivate
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU5886500A (en) 1999-06-23 2001-01-09 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
OA12514A (en) 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2003013510A1 (en) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
TWI317634B (en) * 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
CA2473803A1 (en) 2002-02-01 2003-08-07 Robert Greenhouse Substituted indoles as alpha-1 agonists
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
EP2423190A1 (en) 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
EP1558614B1 (en) * 2002-10-30 2010-09-01 Merck Frosst Canada Ltd. Pyridopyrrolizine and pyridoindolizine derivatives
KR100755580B1 (ko) * 2002-12-03 2007-09-06 에프. 호프만-라 로슈 아게 Ｃｎｓ-장애의 치료를 위한 5-ｈｔ6-수용체 리간드로서의아미노알콕시인돌
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
AU2004283139A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds having CRTH2 antagonist activity
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
CN101454284A (zh) * 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
CA2654026A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
KR20090023645A (ko) 2006-06-28 2009-03-05 사노피-아벤티스 신규한 ｃｘｃｒ2 억제제

Also Published As

Publication number Publication date
US20080051586A1 (en) 2008-02-28
JP2008526936A (ja) 2008-07-24
US7781598B2 (en) 2010-08-24
WO2006075139A3 (en) 2006-10-19
IL183965A0 (en) 2007-10-31
CA2594391A1 (en) 2006-07-20
ZA200705216B (en) 2008-09-25
NO20074047L (no) 2007-08-06
NZ556147A (en) 2010-01-29
CN101102999A (zh) 2008-01-09
WO2006075139A2 (en) 2006-07-20
AU2006205697B2 (en) 2009-01-22
MX2007008348A (es) 2007-08-03
KR20070104350A (ko) 2007-10-25
EP1844012A2 (en) 2007-10-17
BRPI0606639A2 (pt) 2009-07-07
AU2006205697A1 (en) 2006-07-20
CN101102999B (zh) 2010-12-29

Similar Documents

Publication Publication Date Title
GB0514593D0 (en) Process
GB0513866D0 (en) Process
GB0511460D0 (en) Process
GB0501730D0 (en) Process
GB0514698D0 (en) Process
GB0506788D0 (en) Process
GB0516705D0 (en) Process
GB0519758D0 (en) Novel process
GB0526474D0 (en) Novel process
GB0500604D0 (en) Novel process
GB0513978D0 (en) Process
GB0503694D0 (en) Process
GB0501349D0 (en) Process
GB0501102D0 (en) Process
EP1915131A4 (en) PROCESS
GB0516155D0 (en) Process
GB0503528D0 (en) Process
GB0501254D0 (en) Process
GB0501100D0 (en) Process
GB0512662D0 (en) Process
GB0504079D0 (en) Process
GB0505200D0 (en) Process
GB0505221D0 (en) Process
GB0501651D0 (en) Novel process
GB0518287D0 (en) Novel process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)